{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:46:27Z","timestamp":1788608787365,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92879-9","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:28:48Z","timestamp":1741667328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk factors and protective strategies for hypotony following preserflo microshunt implantation"],"prefix":"10.1038","volume":"15","author":[{"given":"Hiroki","family":"Mieno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morio","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"92879_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/ceo.14040","volume":"50","author":"TF Reis","year":"2022","unstructured":"Reis, T. F., Paula, J. S. & Furtado, J. M. Primary glaucomas in adults: epidemiology and public health-A review. Clin. Exp. Ophthalmol. 50, 128\u2013142. https:\/\/doi.org\/10.1111\/ceo.14040 (2022).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"92879_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121, 2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013 (2014).","journal-title":"Ophthalmology"},{"key":"92879_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2147\/OPTH.S80111","volume":"9","author":"A Al Habash","year":"2015","unstructured":"Al Habash, A., Aljasim, L. A., Owaidhah, O. & Edward, D. P. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clin. Ophthalmol. 9, 1945\u20131951. https:\/\/doi.org\/10.2147\/OPTH.S80111 (2015).","journal-title":"Clin. Ophthalmol."},{"key":"92879_CR4","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.ophtha.2013.07.049","volume":"120","author":"JF Kirwan","year":"2013","unstructured":"Kirwan, J. F. et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology 120, 2532\u20132539. https:\/\/doi.org\/10.1016\/j.ophtha.2013.07.049 (2013).","journal-title":"Ophthalmology"},{"key":"92879_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","volume":"119","author":"J Landers","year":"2012","unstructured":"Landers, J., Martin, K., Sarkies, N., Bourne, R. & Watson, P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119, 694\u2013702. https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.043 (2012).","journal-title":"Ophthalmology"},{"key":"92879_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40662-022-00322-1","volume":"10","author":"IIK Ahmed","year":"2023","unstructured":"Ahmed, I. I. K., Sadruddin, O. & Panarelli, J. F. Subconjunctival filtration in evolution: current evidence on microshunt implantation for treating patients with glaucoma. Eye Vis. (Lond). 10, 10. https:\/\/doi.org\/10.1186\/s40662-022-00322-1 (2023).","journal-title":"Eye Vis. (Lond)"},{"key":"92879_CR7","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1111\/aos.16658","volume":"102","author":"A Khan","year":"2024","unstructured":"Khan, A. & Khan, A. U. Comparing the safety and efficacy of preserflo microshunt implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis. Acta Ophthalmol. 102, e443\u2013e451. https:\/\/doi.org\/10.1111\/aos.16658 (2024).","journal-title":"Acta Ophthalmol."},{"key":"92879_CR8","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s00417-023-06075-4","volume":"261","author":"M Jamke","year":"2023","unstructured":"Jamke, M. et al. PRESERFLO microshunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch. Clin. Exp. Ophthalmol. 261, 2901\u20132915. https:\/\/doi.org\/10.1007\/s00417-023-06075-4 (2023).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"92879_CR9","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1111\/aos.14968","volume":"100","author":"KR Pillunat","year":"2022","unstructured":"Pillunat, K. R. et al. PRESERFLO microshunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol. 100, e779\u2013e790. https:\/\/doi.org\/10.1111\/aos.14968 (2022).","journal-title":"Acta Ophthalmol."},{"key":"92879_CR10","doi-asserted-by":"publisher","unstructured":"Pawiroredjo, S. S. M. et al. Efficacy of the PRESERFLO microshunt and a Meta-Analysis of the literature. J. Clin. Med. 11 https:\/\/doi.org\/10.3390\/jcm11237149 (2022).","DOI":"10.3390\/jcm11237149"},{"key":"92879_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/aos.15727","volume":"102","author":"AD Bohler","year":"2024","unstructured":"Bohler, A. D. et al. Hypotony in the early postoperative period after microshunt implantation versus trabeculectomy: A registry study. Acta Ophthalmol. 102, 186\u2013191. https:\/\/doi.org\/10.1111\/aos.15727 (2024).","journal-title":"Acta Ophthalmol."},{"key":"92879_CR12","doi-asserted-by":"publisher","unstructured":"Storp, J. J. et al. Long-Term outcomes of the PRESERFLO microshunt implant in a heterogeneous Glaucoma cohort. J. Clin. Med. 12 https:\/\/doi.org\/10.3390\/jcm12134474 (2023).","DOI":"10.3390\/jcm12134474"},{"key":"92879_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0161-6420(03)00227-6","volume":"110","author":"LA Fannin","year":"2003","unstructured":"Fannin, L. A., Schiffman, J. C. & Budenz, D. L. Risk factors for hypotony maculopathy. Ophthalmology 110, 1185\u20131191. https:\/\/doi.org\/10.1016\/S0161-6420(03)00227-6 (2003).","journal-title":"Ophthalmology"},{"key":"92879_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/IJG.0b013e31816b2fe7","volume":"18","author":"HY Park","year":"2009","unstructured":"Park, H. Y., Lee, N. Y. & Park, C. K. Risk factors of shallow anterior chamber other than hypotony after Ahmed glaucoma valve implant. J. Glaucoma. 18, 44\u201348. https:\/\/doi.org\/10.1097\/IJG.0b013e31816b2fe7 (2009).","journal-title":"J. Glaucoma"},{"key":"92879_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00061198-199504000-00002","volume":"4","author":"SK Seah","year":"1995","unstructured":"Seah, S. K. et al. Hypotony following trabeculectomy. J. Glaucoma. 4, 73\u201379 (1995).","journal-title":"J. Glaucoma"},{"key":"92879_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40123-015-0037-z","volume":"4","author":"M Thomas","year":"2015","unstructured":"Thomas, M., Vajaranant, T. S. & Aref, A. A. Hypotony maculopathy: clinical presentation and therapeutic methods. Ophthalmol. Ther. 4, 79\u201388. https:\/\/doi.org\/10.1007\/s40123-015-0037-z (2015).","journal-title":"Ophthalmol. Ther."},{"key":"92879_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0161-6420(97)30332-7","volume":"104","author":"IJ Suner","year":"1997","unstructured":"Suner, I. J., Greenfield, D. S., Miller, M. P., Nicolela, M. T. & Palmberg, P. F. Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. Ophthalmology 104, 207\u2013214. https:\/\/doi.org\/10.1016\/s0161-6420(97)30332-7 (1997). discussion 214\u2009\u2013\u2009205.","journal-title":"Ophthalmology"},{"key":"92879_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1600-0420.2007.00910.x","volume":"85","author":"VP Costa","year":"2007","unstructured":"Costa, V. P. & Arcieri, E. S. Hypotony maculopathy. Acta Ophthalmol. Scand. 85, 586\u2013597. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.00910.x (2007).","journal-title":"Acta Ophthalmol. Scand."},{"key":"92879_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s0002-9394(14)74720-8","volume":"113","author":"Risk factors for suprachoroidal hemorrhage after filtering surgery","year":"1992","unstructured":"Risk factors for suprachoroidal hemorrhage after filtering surgery. The fluorouracil filtering surgery study group. Am. J. Ophthalmol. 113, 501\u2013507. https:\/\/doi.org\/10.1016\/s0002-9394(14)74720-8 (1992).","journal-title":"Am. J. Ophthalmol."},{"key":"92879_CR20","doi-asserted-by":"publisher","unstructured":"Lupardi, E., Laffi, G. L., Moramarco, A., Barboni, P. & Fontana, L. Systematic preserflo microshunt intraluminal stenting for hypotony prevention in highly myopic patients: A comparative study. J. Clin. Med. 12 https:\/\/doi.org\/10.3390\/jcm12041677 (2023).","DOI":"10.3390\/jcm12041677"},{"key":"92879_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00417-022-05831-2","volume":"261","author":"ME Galimi","year":"2023","unstructured":"Galimi, M. E., Weller, J. M., Kruse, F. E. & Laemmer, R. Risk factors for ocular hypotony after XEN gel stent implantation. Graefes Arch. Clin. Exp. Ophthalmol. 261, 769\u2013778. https:\/\/doi.org\/10.1007\/s00417-022-05831-2 (2023).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"92879_CR22","doi-asserted-by":"publisher","unstructured":"Sadruddin, O., Angeles, P. L., Palmberg, P. & R. & Ab externo implantation of the microshunt, a Poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review. Eye Vis. (Lond). 6 https:\/\/doi.org\/10.1186\/s40662-019-0162-1 (2019).","DOI":"10.1186\/s40662-019-0162-1"},{"key":"92879_CR23","doi-asserted-by":"publisher","unstructured":"Ibarz Barber\u00e1, M. et al. Evaluation of the ultrastructural and in vitro flow properties of the PRESERFLO microshunt. Transl Vis. Sci. Technol. 10 https:\/\/doi.org\/10.1167\/tvst.10.13.26 (2021).","DOI":"10.1167\/tvst.10.13.26"},{"key":"92879_CR24","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1007\/s00417-024-06567-x","volume":"262","author":"R Verma-Fuehring","year":"2024","unstructured":"Verma-Fuehring, R. et al. The use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotony. Graefes Arch. Clin. Exp. Ophthalmol. 262, 3925\u20133932. https:\/\/doi.org\/10.1007\/s00417-024-06567-x (2024).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"92879_CR25","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/ceo.14374","volume":"52","author":"AA Moktar","year":"2024","unstructured":"Moktar, A. A., Ha, J. & Kong, Y. X. G. Routine placement of an intraluminal suture should be considered for preserflo microshunt to prevent early hypotony. Clin. Exp. Ophthalmol. 52, 601\u2013603. https:\/\/doi.org\/10.1111\/ceo.14374 (2024).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"92879_CR26","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s10792-023-02664-8","volume":"43","author":"JN Luke","year":"2023","unstructured":"Luke, J. N. et al. Intraoperative primary partial occlusion of the preserflo microshunt to prevent initial postoperative hypotony. Int. Ophthalmol. 43, 2643\u20132651. https:\/\/doi.org\/10.1007\/s10792-023-02664-8 (2023).","journal-title":"Int. Ophthalmol."},{"key":"92879_CR27","doi-asserted-by":"publisher","first-page":"e60221","DOI":"10.7759\/cureus.60221","volume":"16","author":"Y Miura","year":"2024","unstructured":"Miura, Y., Fukuda, K. & Yamashiro, K. Ab interno intraluminal stent insertion for prolonged hypotony after preserflo microshunt implantation. Cureus 16, e60221. https:\/\/doi.org\/10.7759\/cureus.60221 (2024).","journal-title":"Cureus"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92879-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92879-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92879-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:05:17Z","timestamp":1741709117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92879-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92879"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92879-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kazuhiko Mori received consultant fees from Santen Pharmaceutical Co., Ltd., Morio Ueno received research support from Santen Pharmaceutical Co., Ltd., and Chie Sotozono received grants and personal fees from Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd., played no role in the conduct of the study or in writing the manuscript. All other authors declare no potential conflicts of interest regarding the subjects described in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8344"}}